Urine Metabolites in the Diagnosis of Disease
Part of paid clinical trials in Encinitas, California.
- Sponsor
- Luventix, Inc.
- Study ID
- NCT06710067
- Status
- Recruiting
Conditions
- Celiac Disease
- Colorectal Cancer
- Crohn Disease
- Small Intestinal Bacterial Overgrowth Syndrome (SIBO)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
The goal of this observational study is to validate a non-invasive, urine-based diagnostic technology for the detection and differentiation of various gastrointestinal (GI) diseases. This research study intends to enroll participants across a range of demographics and GI disease states including colorectal cancer, small intestinal bacterial overgrowth (SIBO), Crohn\'s disease, and Celiac disease, collect urine samples and clinical data, and use artificial intelligence and machine learning to build disease-specific models which can identify and differentiate a participants' specific GI disease. The main questions it aims to answer are: 1. Does the platform identify a disease signal within each disease cohort, compared to normal controls? 2. How well does the test perform (e.g. sensitivity and specificity/false-positive rate)?
Key Dates
- Start date
- Oct 1, 2024
- Status verified
- Nov 2024
- Primary completion
- Sep 30, 2025
- Completion
- Sep 30, 2026
Study Design
- Enrollment
- 1,250 participants (estimated)
Arms
- Arm: Disease Cohort
Primary Outcome Measure
Disease signal detection [ Time Frame: From date of enrollment to the end of sample analysis, up to 100 weeks ]
Central Contacts
- Catherine Fine, MS, CGC888-404-3143
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Unio Health Partners (Gastroenterology) | Encinitas | California | 92024 | Robert Goldklang, MD |
| Digestive Health Associates | Santa Monica | California | 90404 | Rahul Dixit, MD |
| Westside Gastro Care | Santa Monica | California | 90404 | David Yamini, MD |
| Bass Medical Group (Gastroenterology) | Walnut Creek | California | 94598 | Rishi Sharma, MD |
Find similar trials in Encinitas, CA
Related Studies
- Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy ProjectRecruiting · University of California, San Diego · La Jolla, California
- ColoCare Study - Colorectal Cancer CohortRecruiting · University of Utah · Los Angeles, California
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Merus B.V. · La Jolla, California
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama